Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — 9M 2023 Earnings Presentation
16 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Nov 2, 2023
Slide 1: 9M Conference Call Drägerwerk AG & Co. KGaA
9M Conference Call Drägerwerk AG & Co. KGaA November 2, 2023, Lübeck Fußzeile: Bitte entsprechende Gesellschaft ergänzen
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Agenda
Agenda — 01 Dräger Business Highlights 02 Financials 9M 2023 03 Outlook FY 2023 Drägerwerk AG & Co. KGaA 3
Slide 4: Dräger Business Highlights
01 Dräger Business Highlights Drägerwerk AG & Co. KGaA 4
Slide 5: Strong 9M performance – successful turnaround to growth and profitability
Strong 9M performance – successful turnaround to growth and profitability • Strong net sales growth due to improved delivery capacity combined with well filled order book from 2022, continued high demand for our products/services as well as extraordinary surge in demand for ventilators in China at t
Slide 6: Financials 9M 2023
02 Financials 9M 2023 Drägerwerk AG & Co. KGaA 6
Slide 7: Business development Group
Business development Group Order entry 9M 2022 9M 2023 Change Net sales (€ million) (fx-adj.) +12.6% +17.1% Europe 1,289.8 1,311.8 2.0% fx-adj fx-adj. +8.8% +14.5% Americas 480.4 517.2 8.2% nominal nominal 2,321 AAA 654.1 574.4 -5.7% 2,027 Total 2,424.2 2,403.3 1.2% 725 789 • Order entry slighty abo
Slide 8: Business development Medical
Business development Medical Order entry 9M 2022 9M 2023 Change Net sales (€ million) (fx-adj.) +7.9% +15.2% Europe 710.6 698.8 -1.5% fx-adj fx-adj. +4.0% +12.5% Americas 315.9 342.6 8.3% nominal nominal 1,359 AAA 435.6 369.3 -9.2% 1,208 Total 1,462.1 1,410.7 -1.7% 431 448 • Order entry below high p
Slide 9: Business development Safety
Business development Safety Order entry 9M 2022 9M 2023 Change Net sales (€ million) (fx-adj.) +19.6% +19.9% Europe 579.1 613.0 6.3% fx-adj fx-adj. +15.9% +17.5% Americas 164.5 174.6 8.2% nominal nominal 962 AAA 218.4 205.1 1.2% 819 Total 962.0 992.7 5.5% 294 340 • Order entry increased, driven by g
Slide 10: Key figures
Key figures 9M 2023 9M 2022 Change € million € million % Cashflow (from operating activities) 46.8 -279.0 >+100 Investments 95.9 89.8 6.7 Cash and cash equivalents 1 181.3 190.4 -5.0 Net financial debt 1 301.7 354.3 -14.8 1 2 Net financial debt / EBITDA 1.1 15.0 Capital employed 1 1,619.9 1,669.7 -3
Slide 11: Outlook FY 2023
03 Outlook FY 2023 Drägerwerk AG & Co. KGaA 11
Slide 12: Outlook
Outlook Results achieved Forecast for Current forecast for fiscal year 2022 fiscal year 2023 (last published) Net sales (net of currency effects) -11.5% 7.0 to 11.0% Upper end Gross margin 40.7% 43.0 to 45.0% Confirmed EBIT margin -2.9% 0.0 to 3.0% 2.0 to 4.0% Dräger Value Added (DVA) EUR -196.2 mil
Slide 13: Questions & Answers
Questions & Answers Drägerwerk AG & Co. KGaA 13
Slide 14: Financial calendar
Financial calendar Dräger publishes preliminary results approximately 2 weeks before the dates of the quarterly reports. Preliminary results for the full year are published in January. March 7, 2024 Annual Report 2023 Conference call April 25, 2024 Report for the first three months 2024 Conference c
Slide 15: Contact
Contact Thomas Fischler | Head of Treasury & Investor Relations Moislinger Alle 53-55 23558 Lübeck, Germany Tel. +49 451 882 2685 Mail: thomas.fischler@draeger.com Nikolaus Hammerschmidt | Investor Relations Manager Moislinger Alle 53-55 23558 Lübeck, Germany Tel. +49 451 882 8903 Mail: nikolaus.ham
Slide 16: Thank you
Thank you 16
Drägerwerk AG & Co. KGaA — 9M 2023 Earnings Presentation on 6ix